Skip to Main Content

Author Details

Eng Hooi Tan
University of Oxford
2009
23
9
PMIDPaper TitleJournal TitlePublished Year
36803587Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression: <i>the ASSURE study</i>.Psychol Med2023
38000766Electronic health records (EHRs) in clinical research and platform trials: Application of the innovative EHR-based methods developed by EU-PEARL.J Biomed Inform2023
37725973Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom.Age Ageing2023
37078398Safety Outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder with Comorbid Depression: The ASSURE Study - CORRIGENDUM.Psychol Med2023
37436441Drug utilization analysis of osteoporosis medications in seven European electronic health databases.Osteoporos Int2023
33550864Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.J Health Psychol2022
35345821Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.Clin Epidemiol2022
34049958Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience.Pediatrics2021
33725121COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.Rheumatology (Oxford)2021
33688639Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS.Res Sq2021
34899334Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis.Front Pharmacol2021
34272262Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.Cancer Epidemiol Biomarkers Prev2021
33948777Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.Breast Cancer Res Treat2021
32844466Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance.Pharmacoepidemiol Drug Saf2020
33269355Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis.medRxiv2020
32652462Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder.Breast2020
30593460Relative criticalness of common laboratory tests for critical value reporting.J Clin Pathol2019
31067292Outcome-Based Critical Result Thresholds in the Adult Patient Population.Am J Clin Pathol2019
29193566Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.Liver Int2018
29986672Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder.BMC Cancer2018
27008039Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.PLoS One2016
20820812How well does the MESTT correlate with CTCAE scale for the grading of dermatological toxicities associated with oral tyrosine kinase inhibitors?Support Care Cancer2011
19755624Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors.Ann Pharmacother2009
  • 1 - 23 of 23

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
Columbia University
Career Start Year 2015
Number of shared co-authors 4
Graduate Institute of Data Science, Taipei Medical University
Career Start Year 2012
Number of shared co-authors 9
HealthPartners Institute
Career Start Year 2011
Number of shared co-authors 2
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2011
Number of shared co-authors 0
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2010
Number of shared co-authors 0
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 1
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 44
Loyola University
Career Start Year 2010
Number of shared co-authors 0
Bayer Pharma AG
Career Start Year 2009
Number of shared co-authors 4
Evidence Foundation
Career Start Year 2008
Number of shared co-authors 0
University of Toronto
Career Start Year 2007
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 6
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 4
College of Public Health, Taipei Medical University
Career Start Year 2004
Number of shared co-authors 9
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 1
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 2
Stanford University
Career Start Year 1997
Number of shared co-authors 1
University of Washington
Career Start Year 1997
Number of shared co-authors 1
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 5
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 3
University Health Network
Career Start Year 1994
Number of shared co-authors 1
Graduate Institute of Biomedical Informatics, Taipei Medical University
Career Start Year 1993
Number of shared co-authors 12
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 3
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 0

Collaborators

University of Oxford
Co-authored papers 9
Columbia University Irving Medical Center
Co-authored papers 7
Columbia University
Co-authored papers 7
Riyadh Elm University
Co-authored papers 7
The University of Manchester, University of Manchester
Co-authored papers 7
University of California los angeles
Co-authored papers 7
Erasmus University Medical Center
Co-authored papers 7
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 6
University of Oxford
Co-authored papers 6
University of Dundee
Co-authored papers 6
Erasmus University Medical Center
Co-authored papers 6
Universidad del Norte
Co-authored papers 6
University of Utah
Co-authored papers 6
University of Gothenburg
Co-authored papers 6
Northeastern University
Co-authored papers 6
Stanford University
Co-authored papers 6
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 5
Yonsei University College of Medicine
Co-authored papers 5
Erasmus University Medical Center
Co-authored papers 5
Columbia University Irving Medical Center
Co-authored papers 5
University of Utah Health
Co-authored papers 5
College of Engineering, University of Arizona
Co-authored papers 5
O'Brien Institute for Public Health, University of Calgary
Co-authored papers 5
Columbia University Irving Medical Center
Co-authored papers 5
Stanford University
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Co-authored papers 4
Ajou University Graduate School of Medicine
Co-authored papers 4
Columbia University
Co-authored papers 3
Janssen Pharmaceutical Research & Development
Co-authored papers 3